Any 0 3 0 3 O
number 4 10 4 10 O
of 11 13 11 13 O
prior 14 19 14 19 B-treatment
lines 20 25 20 25 I-treatment
of 26 28 26 28 I-treatment
chemotherapy 29 41 29 41 I-treatment
in 42 44 42 44 O
the 45 48 45 48 O
metastatic 49 59 49 59 B-cancer
setting 60 67 60 67 O

Concomitant 0 11 68 79 O
use 12 15 80 83 O
of 16 18 84 86 O
bisphosphonates 19 34 87 102 B-treatment

Congestive 0 10 103 113 B-chronic_disease
heart 11 16 114 119 I-chronic_disease
failure 17 24 120 127 I-chronic_disease
, 24 25 127 128 O
Clinically 26 36 129 139 O
significant 37 48 140 151 O
cardiac 49 56 152 159 B-chronic_disease
arrhythmia 57 67 160 170 I-chronic_disease
, 67 68 170 171 O
history 69 76 172 179 O
or 77 79 180 182 O
current 80 87 183 190 O
evidence 88 96 191 199 O
of 97 99 200 202 O
a 100 101 203 204 O
myocardial 102 112 205 215 B-chronic_disease
infarction 113 123 216 226 I-chronic_disease
during 124 130 227 233 O
the 131 134 234 237 O
last 135 139 238 242 B-upper_bound
6 140 141 243 244 I-upper_bound
months 142 148 245 251 I-upper_bound
, 148 149 251 252 O
and/or 150 156 253 259 O
a 157 158 260 261 O
current 159 166 262 269 O
ECG 167 170 270 273 B-treatment
tracing 171 178 274 281 I-treatment
that 179 183 282 286 O
is 184 186 287 289 O
abnormal 187 195 290 298 O
in 196 198 299 301 O
the 199 202 302 305 O
opinion 203 210 306 313 O
of 211 213 314 316 O
the 214 217 317 320 O
treating 218 226 321 329 O
Investigator 227 239 330 342 O
, 239 240 342 343 O
or 241 243 344 346 O
unstable 244 252 347 355 B-chronic_disease
angina 253 259 356 362 I-chronic_disease

Female 0 6 363 369 B-gender
patient 7 14 370 377 O
of 15 17 378 380 O
childbearing 18 30 381 393 O
potential 31 40 394 403 O
must 41 45 404 408 O
have 46 50 409 413 O
a 51 52 414 415 O
negative 53 61 416 424 B-pregnancy
serum 62 67 425 430 I-pregnancy
or 68 70 431 433 I-pregnancy
urine 71 76 434 439 I-pregnancy
pregnancy 77 86 440 449 I-pregnancy
test 87 91 450 454 O
β 92 93 455 456 O
- 93 94 456 457 O
hCG 94 97 457 460 O
within 98 104 461 467 O
72 105 107 468 470 B-upper_bound
hours 108 113 471 476 I-upper_bound
prior 114 119 477 482 I-upper_bound
to 120 122 483 485 O
receiving 123 132 486 495 O
the 133 136 496 499 O
first 137 142 500 505 O
dose 143 147 506 510 O
of 148 150 511 513 O
study 151 156 514 519 B-treatment
medication 157 167 520 530 I-treatment
and 168 171 531 534 O
agree 172 177 535 540 O
to 178 180 541 543 O
the 181 184 544 547 O
use 185 188 548 551 B-contraception_consent
of 189 191 552 554 I-contraception_consent
effective 192 201 555 564 I-contraception_consent
methods 202 209 565 572 I-contraception_consent
of 210 212 573 575 I-contraception_consent
contraception 213 226 576 589 I-contraception_consent
while 227 232 590 595 O
on 233 235 596 598 O
study 236 241 599 604 O

Patient 0 7 605 612 O
is 8 10 613 615 O
male 11 15 616 620 B-gender
or 16 18 621 623 I-gender
female 19 25 624 630 I-gender
and 26 29 631 634 O
≥18 30 33 635 638 O
years 34 39 639 644 I-lower_bound
of 40 42 645 647 O
age 43 46 648 651 B-age
on 47 49 652 654 O
the 50 53 655 658 O
day 54 57 659 662 O
of 58 60 663 665 O
signing 61 68 666 673 O
informed 69 77 674 682 O
consent 78 85 683 690 O

Patient 0 7 691 698 O
must 8 12 699 703 O
have 13 17 704 708 O
histologically 18 32 709 723 O
or 33 35 724 726 O
cytologically 36 49 727 740 O
documented 50 60 741 751 O
solid 61 66 752 757 B-cancer
tumor 67 72 758 763 I-cancer
malignancies 73 85 764 776 I-cancer

Patient 0 7 777 784 O
must 8 12 785 789 O
have 13 17 790 794 O
performance 18 29 795 806 B-clinical_variable
status 30 36 807 813 I-clinical_variable
of 37 39 814 816 O
0 40 41 817 818 B-lower_bound
- 41 42 818 819 O
2 42 43 819 820 B-upper_bound
on 44 46 821 823 O
the 47 50 824 827 O
ECOG 51 55 828 832 B-clinical_variable
Performance 56 67 833 844 I-clinical_variable
Scale 68 73 845 850 I-clinical_variable
and 74 77 851 854 O
life 78 82 855 859 B-clinical_variable
expectancy 83 93 860 870 I-clinical_variable
> 94 95 871 872 O
3 96 97 873 874 B-lower_bound
months 98 104 875 881 I-lower_bound

Patients 0 8 882 890 O
must 9 13 891 895 O
be 14 16 896 898 O
at 17 19 899 901 O
least 20 25 902 907 O
two 26 29 908 911 B-lower_bound
weeks 30 35 912 917 I-lower_bound
from 36 40 918 922 O
a 41 42 923 924 O
major 43 48 925 930 B-treatment
surgical 49 57 931 939 I-treatment
procedure 58 67 940 949 I-treatment
, 67 68 949 950 O
and 69 72 951 954 O
surgical 73 81 955 963 B-treatment
wounds 82 88 964 970 I-treatment
must 89 93 971 975 O
be 94 96 976 978 O
completely 97 107 979 989 O
healed 108 114 990 996 O

Patients 0 8 997 1005 O
must 9 13 1006 1010 O
be 14 16 1011 1013 O
off 17 20 1014 1017 O
steroids 21 29 1018 1026 B-treatment
with 30 34 1027 1031 O
no 35 37 1032 1034 O
new 38 41 1035 1038 O
CNS 42 45 1039 1042 B-chronic_disease
symptoms 46 54 1043 1051 I-chronic_disease
or 55 57 1052 1054 O
findings 58 66 1055 1063 O
on 67 69 1064 1066 O
radiographic 70 82 1067 1079 B-treatment
imaging 83 90 1080 1087 I-treatment
for 91 94 1088 1091 O
1 95 96 1092 1093 O
month 97 102 1094 1099 O

Patients 0 8 1100 1108 O
must 9 13 1109 1113 O
have 14 18 1114 1118 O
histologically 19 33 1119 1133 O
or 34 36 1134 1136 O
cytologically 37 50 1137 1150 O
confirmed 51 60 1151 1160 O
locally 61 68 1161 1168 O
advanced 69 77 1169 1177 O
, 77 78 1177 1178 O
unresectable 79 91 1179 1191 O
or 92 94 1192 1194 O
metastatic 95 105 1195 1205 B-cancer
carcinoma 106 115 1206 1215 I-cancer
of 116 118 1216 1218 I-cancer
the 119 122 1219 1222 I-cancer
breast 123 129 1223 1229 I-cancer

Patients 0 8 1230 1238 O
who 9 12 1239 1242 O
have 13 17 1243 1247 O
had 18 21 1248 1251 O
chemotherapy 22 34 1252 1264 B-treatment
or 35 37 1265 1267 O
radiotherapy 38 50 1268 1280 B-treatment
within 51 57 1281 1287 O
two 58 61 1288 1291 B-upper_bound
weeks 62 67 1292 1297 I-upper_bound
, 67 68 1297 1298 O
4 69 70 1299 1300 B-upper_bound
weeks 71 76 1301 1306 I-upper_bound
for 77 80 1307 1310 O
nitrosoureas 81 93 1311 1323 B-treatment
, 93 94 1323 1324 O
mitomycin 95 104 1325 1334 B-treatment
C 105 106 1335 1336 I-treatment
, 106 107 1336 1337 O
pegylated 108 117 1338 1347 B-treatment
- 117 118 1347 1348 I-treatment
doxorubicin 118 129 1348 1359 I-treatment
and 130 133 1360 1363 O
one 134 137 1364 1367 O
half 138 142 1368 1372 O
- 142 143 1372 1373 O
life 143 147 1373 1377 O
for 148 151 1378 1381 O
bevacizumab 152 163 1382 1393 B-treatment
, 163 164 1393 1394 O
hormone 165 172 1395 1402 B-treatment
therapy 173 180 1403 1410 I-treatment
within 181 187 1411 1417 O
one 188 191 1418 1421 B-upper_bound
week 192 196 1422 1426 I-upper_bound
, 196 197 1426 1427 O
trastuzumab 198 209 1428 1439 B-treatment
within 210 216 1440 1446 O
2 217 218 1447 1448 B-upper_bound
weeks 219 224 1449 1454 I-upper_bound
or 225 227 1455 1457 O
lapatinib 228 237 1458 1467 B-treatment
within 238 244 1468 1474 O
one 245 248 1475 1478 O
week 249 253 1479 1483 O
of 254 256 1484 1486 O
study 257 262 1487 1492 O
Day 263 266 1493 1496 O
1 267 268 1497 1498 O

Patients 0 8 1499 1507 O
with 9 13 1508 1512 O
> 14 15 1513 1514 O
Grade 16 21 1515 1520 B-lower_bound
1 22 23 1521 1522 I-lower_bound
neuropathy 24 34 1523 1533 B-clinical_variable
at 35 37 1534 1536 O
screening 38 47 1537 1546 O

Patients 0 8 1547 1555 O
with 9 13 1556 1560 O
a 14 15 1561 1562 O
hypersensitivity 16 32 1563 1579 O
to 33 35 1580 1582 O
halichondrin 36 48 1583 1595 B-allergy_name
B 49 50 1596 1597 I-allergy_name
and/or 51 57 1598 1604 O
halichondrin 58 70 1605 1617 O
B 71 72 1618 1619 O
chemical 73 81 1620 1628 O
derivative 82 92 1629 1639 O

Patients 0 8 1640 1648 O
with 9 13 1649 1653 O
clinically 14 24 1654 1664 O
insignificant 25 38 1665 1678 O
brain 39 44 1679 1684 B-cancer
metastases 45 55 1685 1695 I-cancer
that 56 60 1696 1700 O
do 61 63 1701 1703 O
not 64 67 1704 1707 O
require 68 75 1708 1715 O
treatment 76 85 1716 1725 B-treatment

Patients 0 8 1726 1734 O
with 9 13 1735 1739 O
known 14 19 1740 1745 O
active 20 26 1746 1752 O
CNS 27 30 1753 1756 B-cancer
metastases 31 41 1757 1767 I-cancer
and/or 42 48 1768 1774 O
carcinomatous 49 62 1775 1788 B-cancer
meningitis 63 73 1789 1799 I-cancer

Patients 0 8 1800 1808 O
with 9 13 1809 1813 O
known 14 19 1814 1819 O
hypersensitivity 20 36 1820 1836 O
to 37 39 1837 1839 O
the 40 43 1840 1843 O
components 44 54 1844 1854 O
of 55 57 1855 1857 O
study 58 63 1858 1863 B-allergy_name
drug 64 68 1864 1868 I-allergy_name
or 69 71 1869 1871 O
its 72 75 1872 1875 O
analogs 76 83 1876 1883 O

Patients 0 8 1884 1892 O
with 9 13 1893 1897 O
non 14 17 1898 1901 O
- 17 18 1901 1902 O
healing 18 25 1902 1909 O
surgical 26 34 1910 1918 B-treatment
wounds 35 41 1919 1925 O

Patients 0 8 1926 1934 O
with 9 13 1935 1939 O
other 14 19 1940 1945 O
active 20 26 1946 1952 O
, 26 27 1952 1953 O
current 28 35 1954 1961 O
primary 36 43 1962 1969 B-cancer
malignancies 44 56 1970 1982 I-cancer
, 56 57 1982 1983 O
other 58 63 1984 1989 O
than 64 68 1990 1994 O
carcinoma 69 78 1995 2004 B-cancer
in 79 81 2005 2007 I-cancer
situ 82 86 2008 2012 I-cancer
of 87 89 2013 2015 O
the 90 93 2016 2019 O
cervix 94 100 2020 2026 O
or 101 103 2027 2029 O
non 104 107 2030 2033 B-cancer
- 107 108 2033 2034 I-cancer
melanoma 108 116 2034 2042 I-cancer
skin 117 121 2043 2047 I-cancer
cancer 122 128 2048 2054 I-cancer

Patients 0 8 2055 2063 O
with 9 13 2064 2068 O
other 14 19 2069 2074 O
significant 20 31 2075 2086 B-chronic_disease
disease 32 39 2087 2094 I-chronic_disease
or 40 42 2095 2097 O
disorders 43 52 2098 2107 O
that 53 57 2108 2112 O
, 57 58 2112 2113 O
in 59 61 2114 2116 O
the 62 65 2117 2120 O
Investigator 66 78 2121 2133 O
's 78 80 2133 2135 O
opinion 81 88 2136 2143 O

Patients 0 8 2144 2152 O
with 9 13 2153 2157 O
stable 14 20 2158 2164 O
and 21 24 2165 2168 O
clinically 25 35 2169 2179 O
insignificant 36 49 2180 2193 O
CNS 50 53 2194 2197 B-chronic_disease
disease 54 61 2198 2205 I-chronic_disease

QTc 0 3 2206 2209 B-clinical_variable
prolongation 4 16 2210 2222 I-clinical_variable
> 17 18 2223 2224 O
480 18 21 2224 2227 B-lower_bound
msec 22 26 2228 2232 I-lower_bound
( 27 28 2233 2234 O
Bazett 28 34 2234 2240 O
's 34 36 2240 2242 O
Formula 37 44 2243 2250 O
) 44 45 2250 2251 O
or 46 48 2252 2254 O
congenitally 49 61 2255 2267 O
long 62 66 2268 2272 O
QT 67 69 2273 2275 B-chronic_disease
syndrome 70 78 2276 2284 I-chronic_disease

Severe 0 6 2285 2291 O
/ 6 7 2291 2292 O
uncontrolled 7 19 2292 2304 O
concurrent 20 30 2305 2315 O
illness 31 38 2316 2323 O
/ 38 39 2323 2324 O
infection 39 48 2324 2333 B-chronic_disease

Significant 0 11 2334 2345 O
cardiovascular 12 26 2346 2360 B-chronic_disease
impairment 27 37 2361 2371 I-chronic_disease

no 0 2 2372 2374 O
evidence 3 11 2375 2383 O
of 12 14 2384 2386 O
new 15 18 2387 2390 O
or 19 21 2391 2393 O
enlarging 22 31 2394 2403 O
CNS 32 35 2404 2407 B-cancer
metastasis 36 46 2408 2418 I-cancer

off 0 3 2419 2422 O
steroids 4 12 2423 2431 B-treatment
that 13 17 2432 2436 O
are 18 21 2437 2440 O
used 22 26 2441 2445 O
to 27 29 2446 2448 O
minimize 30 38 2449 2457 O
surrounding 39 50 2458 2469 O
brain 51 56 2470 2475 B-chronic_disease
edema 57 62 2476 2481 I-chronic_disease

patients 0 8 2482 2490 O
with 9 13 2491 2495 O
CNS 14 17 2496 2499 B-cancer
metastases 18 28 2500 2510 I-cancer
who 29 32 2511 2514 O
have 33 37 2515 2519 O
completed 38 47 2520 2529 O
a 48 49 2530 2531 O
course 50 56 2532 2538 O
of 57 59 2539 2541 O
therapy 60 67 2542 2549 B-treatment
would 68 73 2550 2555 O
be 74 76 2556 2558 O
eligible 77 85 2559 2567 O
for 86 89 2568 2571 O
the 90 93 2572 2575 O
study 94 99 2576 2581 O
provided 100 108 2582 2590 O
they 109 113 2591 2595 O
are 114 117 2596 2599 O
clinically 118 128 2600 2610 O
stable 129 135 2611 2617 O
for 136 139 2618 2621 O
at 140 142 2622 2624 O
least 143 148 2625 2630 O
1 149 150 2631 2632 B-lower_bound
month 151 156 2633 2638 I-lower_bound
prior 157 162 2639 2644 I-lower_bound
to 163 165 2645 2647 O
entry 166 171 2648 2653 O

pregnant 0 8 2654 2662 B-pregnancy

